Mg2+ Imparts NMDA Receptor Subtype Selectivity to the Alzheimer's Drug Memantine
暂无分享,去创建一个
[1] M. Annetta,et al. Ketamine: new indications for an old drug. , 2005, Current drug targets.
[2] Jon W. Johnson,et al. Trapping channel block of NMDA-activated responses by amantadine and memantine. , 1997, Journal of neurophysiology.
[3] A. Sobolevsky,et al. Interaction of memantine and amantadine with agonist‐unbound NMDA‐receptor channels in acutely isolated rat hippocampal neurons , 1998, The Journal of physiology.
[4] S. Lipton. Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond , 2006, Nature Reviews Drug Discovery.
[5] M. D'Andrea,et al. Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons. , 2006, Current pharmaceutical design.
[6] P. Banerjee,et al. Comments on “Memantine Blocks α7* Nicotinic Acetylcholine Receptors More Potently Than N-Methyl-d-aspartate Receptors in Rat Hippocampal Neurons” , 2005, Journal of Pharmacology and Experimental Therapeutics.
[7] D. Javitt,et al. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia , 2008, Trends in Neurosciences.
[8] K. Williams,et al. Channel blockers acting at N-methyl-D-aspartate receptors: differential effects of mutations in the vestibule and ion channel pore. , 2002, Molecular pharmacology.
[9] P. Greengard,et al. Regulation of NMDA receptor trafficking by amyloid-beta. , 2005, Nature neuroscience.
[10] S. Lipton,et al. Pharmacological Implications of Two Distinct Mechanisms of Interaction of Memantine with N-Methyl-d-aspartate-Gated Channels , 2005, Journal of Pharmacology and Experimental Therapeutics.
[11] T. Yamakura,et al. Different sensitivities of NMDA receptor channel subtypes to non-competitive antagonists. , 1993, Neuroreport.
[12] R. Greene. Circuit analysis of NMDAR hypofunction in the hippocampus, in vitro, and psychosis of schizophrenia † , 2001, Hippocampus.
[13] K. Bell,et al. Altered synaptic function in Alzheimer's disease. , 2006, European journal of pharmacology.
[14] R. Dingledine,et al. The glutamate receptor ion channels. , 1999, Pharmacological reviews.
[15] N. Newberry,et al. Inhibition of human alpha 7 nicotinic acetylcholine receptors by open channel blockers of N-methyl-D-aspartate receptors. , 2003, British journal of pharmacology.
[16] K. Sakimura,et al. Molecular diversity of the NMDA receptor channel , 1992, Nature.
[17] A. Belger,et al. NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development , 2003, Psychopharmacology.
[18] Jon W. Johnson,et al. Permeant Ion Effects on External Mg2+ Block of NR1/2D NMDA Receptors , 2006, The Journal of Neuroscience.
[19] A. Maelicke,et al. Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than n-methyl-D-aspartate receptors in rat hippocampal neurons. , 2005, The Journal of pharmacology and experimental therapeutics.
[20] B. Sakmann,et al. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors , 1994, Neuron.
[21] H. Schmitt,et al. On the paradox of ion channel blockade and its benefits in the treatment of Alzheimer disease. , 2005, Medical hypotheses.
[22] S. Dravid,et al. Subunit‐specific mechanisms and proton sensitivity of NMDA receptor channel block , 2007, The Journal of physiology.
[23] S. Cull-Candy,et al. Role of Distinct NMDA Receptor Subtypes at Central Synapses , 2004, Science's STKE.
[24] Chris G. Parsons,et al. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse , 2007, Neuropharmacology.
[25] A. Maelicke,et al. Memantine Blocks α7* Nicotinic Acetylcholine Receptors More Potently Than N-Methyl-D-aspartate Receptors in Rat Hippocampal Neurons , 2005, Journal of Pharmacology and Experimental Therapeutics.
[26] N. Newberry,et al. Inhibition of human α7 nicotinic acetylcholine receptors by open channel blockers of N‐methyl‐D‐aspartate receptors , 2003 .
[27] M. Hollmann,et al. Modulation of NMDA Receptor Function by Ketamine and Magnesium: Part I , 2001, Anesthesia and analgesia.
[28] J. Ruppersberg,et al. Memantine inhibits efferent cholinergic transmission in the cochlea by blocking nicotinic acetylcholine receptors of outer hair cells. , 2001, Molecular pharmacology.
[29] M. Ansseau,et al. Nitrous Oxide and Xenon Prevent Amphetamine-Induced Carrier-Mediated Dopamine Release in a Memantine-Like Fashion and Protect Against Behavioral Sensitization , 2006, Biological Psychiatry.
[30] Karim Le Meur,et al. Tonic activation of NMDA receptors by ambient glutamate of non‐synaptic origin in the rat hippocampus , 2007, The Journal of physiology.
[31] T. Kuner,et al. Multiple Structural Elements Determine Subunit Specificity of Mg2+ Block in NMDA Receptor Channels , 1996, The Journal of Neuroscience.
[32] M. Rogawski,et al. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease. , 2006, CNS drug reviews.
[33] B. Moghaddam,et al. NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal Neurons , 2007, The Journal of Neuroscience.
[34] I. Módy,et al. Actions of ketamine, phencyclidine and MK‐801 on NMDA receptor currents in cultured mouse hippocampal neurones. , 1991, The Journal of physiology.
[35] M. Bennett,et al. Interaction of Mg2+ and phencyclidine in use-dependent block of NMDA channels , 1991, Neuroscience Letters.
[36] Jon W. Johnson,et al. Mechanism of action of memantine. , 2006, Current opinion in pharmacology.